Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.

Venkataraman GM, Yatin M, Marcinek R, Ain KB.

J Clin Endocrinol Metab. 1999 Jul;84(7):2449-57.

PMID:
10404820
2.

Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.

Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M.

Eur J Endocrinol. 1999 Nov;141(5):443-57. Review.

3.

Gene therapy with sodium/iodide symporter in hepatocarcinoma.

Haberkorn U.

Exp Clin Endocrinol Diabetes. 2001;109(1):60-2. Review.

PMID:
11573143
4.

Implications of the molecular characterization of the sodium-iodide symporter (NIS).

Schmutzler C, Köhrle J.

Exp Clin Endocrinol Diabetes. 1998;106 Suppl 3:S1-10. Review.

PMID:
9865544
5.

Regulation of the sodium/iodide symporter by retinoids--a review.

Schmutzler C.

Exp Clin Endocrinol Diabetes. 2001;109(1):41-4. Review.

PMID:
11573138
6.

Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.

Kogai T, Taki K, Brent GA.

Endocr Relat Cancer. 2006 Sep;13(3):797-826. Review.

7.

Sodium/iodide symporter in thyroid cancer.

Mian C, Lacroix L, Bidart JM, Caillou B, Filetti S, Schlumberger M.

Exp Clin Endocrinol Diabetes. 2001;109(1):47-51. Review. No abstract available.

PMID:
11573140
8.

Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.

De La Vieja A, Dohan O, Levy O, Carrasco N.

Physiol Rev. 2000 Jul;80(3):1083-105. Review.

9.

Gene methylation in thyroid tumorigenesis.

Xing M.

Endocrinology. 2007 Mar;148(3):948-53. Epub 2006 Aug 31. Review.

PMID:
16946009
10.

Flavonoids, Thyroid Iodide Uptake and Thyroid Cancer-A Review.

Gonçalves CFL, de Freitas ML, Ferreira ACF.

Int J Mol Sci. 2017 Jun 12;18(6). pii: E1247. doi: 10.3390/ijms18061247. Review.

11.

Innovative strategies for the treatment of thyroid cancer.

Schmutzler C, Koehrle J.

Eur J Endocrinol. 2000 Jul;143(1):15-24. Review.

12.

Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy.

Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC.

J Clin Endocrinol Metab. 2001 Jul;86(7):3327-35. Review. No abstract available.

PMID:
11443208
13.

Update on the thyroid sodium iodide symporter: a novel thyroid antigen emerging on the horizon.

Spitzweg C, Heufelder AE.

Eur J Endocrinol. 1997 Jul;137(1):22-3. Review. No abstract available.

14.

Retinoic acid redifferentiation therapy for thyroid cancer.

Schmutzler C, Köhrle J.

Thyroid. 2000 May;10(5):393-406. Review.

PMID:
10884186
15.

Regulation of sodium/iodide symporter.

Jhiang SM.

Rev Endocr Metab Disord. 2000 Apr;1(3):205-15. Review. No abstract available.

PMID:
11705005
16.

Mutations and disorders involving the thyroid iodide transporter--the next wave in thyroid diseases.

Morris JC.

J Clin Endocrinol Metab. 1997 Dec;82(12):3964-5. Review. No abstract available.

PMID:
9398696
17.

Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer.

Tesselaar MH, Smit JW, Nagarajah J, Netea-Maier RT, Plantinga TS.

J Mol Endocrinol. 2017 Nov;59(4):R141-R154. doi: 10.1530/JME-17-0134. Epub 2017 Sep 20. Review.

PMID:
28931558

Supplemental Content

Support Center